$CVR
CHICAGO RIVET & MACHINE CO

2023 Q3 Form 10-Q Financial Statement

#000119312523204957 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $7.946M $8.051M
YoY Change -7.26% -10.78%
Cost Of Revenue $7.905M $8.380M
YoY Change 6.14% 10.6%
Gross Profit $41.15K -$329.0K
YoY Change -96.33% -122.75%
Gross Profit Margin 0.52% -4.09%
Selling, General & Admin $1.273M $1.359M
YoY Change 1.82% 7.56%
% of Gross Profit 3093.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $308.3K $306.1K
YoY Change -3.44% -4.48%
% of Gross Profit 749.2%
Operating Expenses $1.273M $1.359M
YoY Change -136.5% 7.56%
Operating Profit -$1.232M -$1.689M
YoY Change -126.74% -1025.43%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $16.98K $23.00K
YoY Change 29.19% 84.73%
Pretax Income -$1.215M -$1.666M
YoY Change -126.29% -954.53%
Income Tax -$251.0K -$354.0K
% Of Pretax Income
Net Earnings -$964.0K -$1.312M
YoY Change -126.94% -952.16%
Net Earnings / Revenue -12.13% -16.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.00 -$1.36
COMMON SHARES
Basic Shares Outstanding 966.1K shares 966.1K shares
Diluted Shares Outstanding 966.1K shares 966.1K shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.563M $3.218M
YoY Change -68.24% -10.7%
Cash & Equivalents $2.363M $1.524M
Short-Term Investments $200.0K $1.694M
Other Short-Term Assets $412.9K $422.0K
YoY Change -2.16% -0.66%
Inventory $8.795M $9.423M
Prepaid Expenses
Receivables $5.806M $5.904M
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.19M $19.95M
YoY Change -27.2% -2.6%
LONG-TERM ASSETS
Property, Plant & Equipment $11.89M $12.01M
YoY Change -0.14% -0.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.89M $12.01M
YoY Change -0.14% -0.29%
TOTAL ASSETS
Total Short-Term Assets $18.19M $19.95M
Total Long-Term Assets $11.89M $12.01M
Total Assets $30.09M $31.96M
YoY Change -18.47% -1.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.008M $1.234M
YoY Change 12.3% 14.76%
Accrued Expenses $147.5K $84.24K
YoY Change -64.16% -71.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.234M $2.432M
YoY Change -35.92% -2.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.234M $2.432M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.479M $3.296M
YoY Change -43.5% -2.65%
SHAREHOLDERS EQUITY
Retained Earnings $29.94M $31.00M
YoY Change -14.08% -1.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.922M $3.922M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $27.61M $28.67M
YoY Change
Total Liabilities & Shareholders Equity $30.09M $31.96M
YoY Change -18.47% -1.75%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$964.0K -$1.312M
YoY Change -126.94% -952.16%
Depreciation, Depletion And Amortization $308.3K $306.1K
YoY Change -3.44% -4.48%
Cash From Operating Activities -$369.0K -$712.7K
YoY Change -395.93% 378.21%
INVESTING ACTIVITIES
Capital Expenditures $189.6K $346.8K
YoY Change -139.15% -480.67%
Acquisitions
YoY Change
Other Investing Activities $1.494M $530.5K
YoY Change -70.35%
Cash From Investing Activities $1.304M $183.7K
YoY Change -71.36% -301.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -96.61K -212.6K
YoY Change -54.55% 0.0%
NET CHANGE
Cash From Operating Activities -369.0K -712.7K
Cash From Investing Activities 1.304M 183.7K
Cash From Financing Activities -96.61K -212.6K
Net Change In Cash 838.8K -741.6K
YoY Change -81.22% 63.81%
FREE CASH FLOW
Cash From Operating Activities -$369.0K -$712.7K
Capital Expenditures $189.6K $346.8K
Free Cash Flow -$558.6K -$1.060M
YoY Change -191.71% 1729.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Entity File Number
EntityFileNumber
000-01227
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-0904920
dei Entity Address Address Line1
EntityAddressAddressLine1
901 Frontenac Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Naperville
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60563
dei City Area Code
CityAreaCode
630
dei Local Phone Number
LocalPhoneNumber
357-8500
dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
dei Trading Symbol
TradingSymbol
CVR
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
966132 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1524167 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4045101 usd
CY2023Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
1694000 usd
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2691000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
146000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5904401 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4975137 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
9423243 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
9121230 usd
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
985119 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
509119 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
421999 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
422747 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
19952929 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21764334 usd
CY2023Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
1510513 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
1510513 usd
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6758266 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6758266 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
37778206 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
37080762 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46046985 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45349541 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34037051 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33487748 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12009934 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11861793 usd
CY2023Q2 us-gaap Assets
Assets
31962863 usd
CY2022Q4 us-gaap Assets
Assets
33626127 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1234323 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
697235 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
577657 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
462332 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
84244 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
327961 usd
CY2023Q2 us-gaap Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
535498 usd
CY2022Q4 us-gaap Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
203717 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2431722 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1691245 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
864084 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
948084 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3295806 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2639329 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1138096 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1138096 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
966132 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
966132 shares
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1138096 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1138096 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447134 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447134 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31003925 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33323666 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3922098 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3922098 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28667057 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
30986798 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31962863 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33626127 usd
CY2023Q2 us-gaap Revenues
Revenues
8050931 usd
CY2022Q2 us-gaap Revenues
Revenues
9023398 usd
us-gaap Revenues
Revenues
16780656 usd
us-gaap Revenues
Revenues
18221094 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
8379967 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
7577021 usd
us-gaap Cost Of Revenue
CostOfRevenue
16632189 usd
us-gaap Cost Of Revenue
CostOfRevenue
14918495 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-329036 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1446377 usd
us-gaap Gross Profit
GrossProfit
148467 usd
us-gaap Gross Profit
GrossProfit
3302599 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1359465 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1263921 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2617160 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2559585 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1688501 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
182456 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2468693 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
743014 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22995 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12448 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
66050 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22203 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1665506 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
194904 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2402643 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
765217 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-354000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-508000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
164000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1311506 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
153904 usd
us-gaap Net Income Loss
NetIncomeLoss
-1894643 usd
us-gaap Net Income Loss
NetIncomeLoss
601217 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.36
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.16
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.96
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.62
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.36
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.16
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.96
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.62
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
30986798 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-583137 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2023Q1 us-gaap Dividends
Dividends
212549 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30191112 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1311506 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2023Q2 us-gaap Dividends
Dividends
212549 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28667057 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28969365 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
447313 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q1 us-gaap Dividends
Dividends
212549 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
29204129 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
153904 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q2 us-gaap Dividends
Dividends
212549 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
29145484 usd
us-gaap Net Income Loss
NetIncomeLoss
-1894643 usd
us-gaap Net Income Loss
NetIncomeLoss
601217 usd
us-gaap Depreciation
Depreciation
612107 usd
us-gaap Depreciation
Depreciation
640848 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-31500 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-84000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-46000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-929264 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1194243 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-302013 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1095593 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-475252 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-78145 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
537088 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
382910 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
115325 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
235473 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-243717 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
91825 usd
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
331781 usd
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-75713 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2364088 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-537421 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
760248 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
211703 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31500 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
997000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
268252 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-211703 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
425098 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
425098 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-425098 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-425098 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2520934 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1174222 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4045101 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036954 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1524167 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
862732 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16780656 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18221094 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8050931 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9023398 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16780656 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18221094 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Arial;margin:0">2.  The Company extends credit on the basis of terms that are customary within our markets to various companies doing business primarily in the automotive industry.  The Company has a concentration of credit risk primarily within the automotive industry and in the Midwestern United States.  The Company has established an allowance for accounts that may become uncollectible in the future.  This estimated allowance is based in part on management's evaluation of the financial condition of the customer and historical experience.  The Company monitors its accounts receivable and charges to expense an amount equal to its estimate of potential credit losses.  The Company considers a number of factors in determining its estimates, including the length of time its trade accounts receivable are past due, the Company's previous loss history and the customer's current ability to pay its obligation.  The Company also considers current economic conditions, the economic outlook and industry-specific factors in its evaluation.  Accounts receivable balances are charged off against the allowance when it is determined that the receivable will not be recovered.</p>
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8050931 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9023398 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4466826 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4460071 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2939353 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2747427 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2638064 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2534732 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
10044243 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
9742230 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
621000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
621000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
9423243 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
9121230 usd

Files In Submission

Name View Source Status
cvr-20230630_def.xml Edgar Link unprocessable
cvr-20230630_pre.xml Edgar Link unprocessable
0001193125-23-204957-index-headers.html Edgar Link pending
0001193125-23-204957-index.html Edgar Link pending
0001193125-23-204957.txt Edgar Link pending
0001193125-23-204957-xbrl.zip Edgar Link pending
cvr-20230630.xsd Edgar Link pending
d440811d10q.htm Edgar Link pending
d440811dex311.htm Edgar Link pending
d440811dex312.htm Edgar Link pending
d440811dex321.htm Edgar Link pending
d440811dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
cvr-20230630_cal.xml Edgar Link unprocessable
cvr-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d440811d10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending